Venture capitalists poured $2.6 billion into healthcare startups in January, and several healthcare venture capital deals were announced in the first half of February.
Below are 13 healthcare venture capital deals announced in the past month.
1. Vicarious Surgical, a Cambridge, Mass.-based developer of virtual reality software for minimally invasive surgery procedures, completed a $10 million funding round led by Bill Gates' Gates Frontier.
2. Vor Biopharma, a Boston-based stem cell therapy startup focused on the treatment of hematological malignancies, completed a $42 million Series A financing round led by 5AM Ventures and RA Capital Management.
3. Phylagen, a San Francisco-based data analytics company building an environmental microbiome database, raised $14 million in Series A funding from Cultivan Sandbox, Breakout Ventures and Working Capital.
4. Nuvaira, a Minneapolis-based developer of therapeutic medical devices to treat obstructive lung disease, closed a $79 million equity financing led by U.S. Venture Partners.
5. Culture Biosciences, a South San Francisco-based biotechnology company, raised $5.5 million in a funding round led by Section 32.
6. KenSci, a Seattle-based risk prediction platform for healthcare, closed $22 million in Series B funding. Polaris Partners led the funding round.
7. Health Catalyst, a Salt Lake City-based data and analytics company, raised $100 million in Series F equity and debt funding. OrbiMed led the funding round.
8. HiberCell, a New York City-based biotechnology company, raised $60.75 million in Series A funding. Arch Venture Partners led the funding round.
9. Day Zero Diagnostics, a Boston-based infectious disease diagnostic company, completed an $8.6 million Series A funding round led by Triventures.
10. Clover Health, a San Francisco-based health insurance startup, completed a $500 million funding round led by Greenoaks Capital Management.
11. Dewpoint Therapeutics, a Cambridge, Mass.-based drug discovery startup, completed a $60 million Series A funding round led by Polaris Partners.
12. Phynd Technologies, a Dallas-based information management platform, completed an $8 million Series B funding round. Participating investors included MemorialCare Innovation Fund, Rex Ventures, Orlando Healthcare Ventures and Dallas Venture Partners.
13. Lyndra Therapeutics, a Watertown, Mass.-based biotechnology startup, raised $55 million in Series B financing. Polaris Partners led the funding round.
More articles on healthcare finance:
Investment losses hit Duke University Health System's bottom line
Arkansas hospital's power temporarily shut off due to nonpayment
Wake Forest Baptist sees operating income sink 54% in Q2